PortfoliosLab logo
BIIB vs. SPY
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between BIIB and SPY is 0.42, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.0
Correlation: 0.4

Performance

BIIB vs. SPY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Biogen Inc. (BIIB) and SPDR S&P 500 ETF (SPY). The values are adjusted to include any dividend payments, if applicable.

0.00%5,000.00%10,000.00%15,000.00%December2025FebruaryMarchAprilMay
10,487.98%
2,217.94%
BIIB
SPY

Key characteristics

Sharpe Ratio

BIIB:

-1.53

SPY:

0.72

Sortino Ratio

BIIB:

-2.29

SPY:

1.13

Omega Ratio

BIIB:

0.74

SPY:

1.17

Calmar Ratio

BIIB:

-0.56

SPY:

0.76

Martin Ratio

BIIB:

-1.45

SPY:

3.04

Ulcer Index

BIIB:

29.33%

SPY:

4.72%

Daily Std Dev

BIIB:

27.82%

SPY:

20.06%

Max Drawdown

BIIB:

-90.00%

SPY:

-55.19%

Current Drawdown

BIIB:

-74.05%

SPY:

-7.25%

Returns By Period

In the year-to-date period, BIIB achieves a -19.22% return, which is significantly lower than SPY's -3.01% return. Over the past 10 years, BIIB has underperformed SPY with an annualized return of -10.79%, while SPY has yielded a comparatively higher 12.45% annualized return.


BIIB

YTD

-19.22%

1M

-5.93%

6M

-28.92%

1Y

-42.14%

5Y*

-15.90%

10Y*

-10.79%

SPY

YTD

-3.01%

1M

0.40%

6M

-0.12%

1Y

13.65%

5Y*

16.65%

10Y*

12.45%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

BIIB vs. SPY — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BIIB
The Risk-Adjusted Performance Rank of BIIB is 66
Overall Rank
The Sharpe Ratio Rank of BIIB is 00
Sharpe Ratio Rank
The Sortino Ratio Rank of BIIB is 11
Sortino Ratio Rank
The Omega Ratio Rank of BIIB is 33
Omega Ratio Rank
The Calmar Ratio Rank of BIIB is 1717
Calmar Ratio Rank
The Martin Ratio Rank of BIIB is 99
Martin Ratio Rank

SPY
The Risk-Adjusted Performance Rank of SPY is 7272
Overall Rank
The Sharpe Ratio Rank of SPY is 6969
Sharpe Ratio Rank
The Sortino Ratio Rank of SPY is 7171
Sortino Ratio Rank
The Omega Ratio Rank of SPY is 7373
Omega Ratio Rank
The Calmar Ratio Rank of SPY is 7676
Calmar Ratio Rank
The Martin Ratio Rank of SPY is 7373
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

BIIB vs. SPY - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Biogen Inc. (BIIB) and SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The chart of Sharpe ratio for BIIB, currently valued at -1.53, compared to the broader market-2.00-1.000.001.002.003.00
BIIB: -1.53
SPY: 0.72
The chart of Sortino ratio for BIIB, currently valued at -2.29, compared to the broader market-6.00-4.00-2.000.002.004.00
BIIB: -2.29
SPY: 1.13
The chart of Omega ratio for BIIB, currently valued at 0.74, compared to the broader market0.501.001.502.00
BIIB: 0.74
SPY: 1.17
The chart of Calmar ratio for BIIB, currently valued at -0.56, compared to the broader market0.001.002.003.004.005.00
BIIB: -0.56
SPY: 0.76
The chart of Martin ratio for BIIB, currently valued at -1.45, compared to the broader market-40.00-30.00-20.00-10.000.0010.0020.00
BIIB: -1.45
SPY: 3.04

The current BIIB Sharpe Ratio is -1.53, which is lower than the SPY Sharpe Ratio of 0.72. The chart below compares the historical Sharpe Ratios of BIIB and SPY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-2.00-1.000.001.002.003.00December2025FebruaryMarchAprilMay
-1.53
0.72
BIIB
SPY

Dividends

BIIB vs. SPY - Dividend Comparison

BIIB has not paid dividends to shareholders, while SPY's dividend yield for the trailing twelve months is around 1.26%.


TTM20242023202220212020201920182017201620152014
BIIB
Biogen Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
SPY
SPDR S&P 500 ETF
1.26%1.21%1.40%1.65%1.20%1.52%1.75%2.04%1.80%2.03%2.06%1.87%

Drawdowns

BIIB vs. SPY - Drawdown Comparison

The maximum BIIB drawdown since its inception was -90.00%, which is greater than SPY's maximum drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for BIIB and SPY. For additional features, visit the drawdowns tool.


-80.00%-60.00%-40.00%-20.00%0.00%December2025FebruaryMarchAprilMay
-74.05%
-7.25%
BIIB
SPY

Volatility

BIIB vs. SPY - Volatility Comparison

The current volatility for Biogen Inc. (BIIB) is 13.59%, while SPDR S&P 500 ETF (SPY) has a volatility of 15.07%. This indicates that BIIB experiences smaller price fluctuations and is considered to be less risky than SPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%5.00%10.00%15.00%December2025FebruaryMarchAprilMay
13.59%
15.07%
BIIB
SPY